Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01393
|
|||||
| Drug Name |
Oxyphenonium
|
|||||
| Synonyms |
Argicillin; Atrenyl; Hydroxymethylgramicidin; Methacin; Methocidin; Methocidine; Methocidinum; Metocidina; Oxiphenonum; Spastrex;Oxyphenonium Chloride; Oxyphenonium Iodide; Methocidin [DCF:INN]; Methocidine [INN-French]; Methocidinum [INN-Latin]; Metocidina [INN-Spanish]; [2-(2-Cyclohexyl-2-hydroxy-2-phenyl-acetoxy)-ethyl]-diethyl-methyl-ammonium; 2-((Cyclohexylhydroxyphenylacetyl)oxy)-N,N-diethyl-N-methylethanaminium; 2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium; 2-[2-cyclohexyl(hydroxy)phenylacetoxy]-n,n-diethyl-n-methylethanaminium
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Visceral spasms [ICD11: MD81.4] | Approved | [1] | |||
| Therapeutic Class |
Parasympatholytics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H34NO3+
|
|||||
| Canonical SMILES |
CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
|
|||||
| InChI |
InChI=1S/C21H34NO3/c1-4-22(3,5-2)16-17-25-20(23)21(24,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6,8-9,12-13,19,24H,4-5,7,10-11,14-17H2,1-3H3/q+1
|
|||||
| InChIKey |
GFRUPHOKLBPHTQ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 50-10-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 348.5 | Topological Polar Surface Area | 46.5 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
4.1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
6786040
, 6805132
, 8153527
, 10589783
, 25687908
, 29224786
, 46508840
, 50064410
, 50421464
, 57322928
, 85209563
, 92729657
, 103113595
, 104171383
, 104310145
, 105057325
, 117579885
, 124596745
, 124883575
, 124883576
, 124968859
, 127947311
, 134338369
, 134991339
, 135263553
, 137148160
, 160963567
, 164077978
, 166265001
, 178103831
, 179225198
, 179418658
, 215721396
, 226599816
|
|||||
| ChEBI ID |
CHEBI:94329
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Oxyphenonium was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.